Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia. - Wikidata - wikimedia - TriplyDB

Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia.

Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q33841975

about

Oxidative stress responses and NRF2 in human leukaemia Nrf2 regulates chronic lung inflammation and B-cell responses to nontypeable Haemophilus influenzae The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?Proteomic profiling of acrolein adducts in human lung epithelial cells Individual expression features of GPX2, NQO1 and SQSTM1 transcript variants induced by hydrogen peroxide treatment in HeLa cells.Low-Dose Dose-Response for In Vitro Nrf2-ARE Activation in Human HepG2 Cells Functional Foods for Health: The Interrelated Antioxidant and Anti-Inflammatory Role of Fruits, Vegetables, Herbs, Spices and Cocoa in Humans.Caffeic acid phenethyl amide ameliorates ischemia/reperfusion injury and cardiac dysfunction in streptozotocin-induced diabetic rats.Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia.Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model.In vivo and in vitro effects of heme oxygenase-1 silencing on the survival of acute myelocytic leukemia-M2 cells.Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate.Luteolin and Apigenin Attenuate 4-Hydroxy-2-Nonenal-Mediated Cell Death through Modulation of UPR, Nrf2-ARE and MAPK Pathways in PC12 Cells.Activation of the Nrf2 Cell Defense Pathway by Ancient Foods: Disease Prevention by Important Molecules and Microbes Lost from the Modern Western Diet.Bortezomib induces heme oxygenase-1 expression in multiple myeloma HO-1, RET and PML as possible markers for risk stratification of acute myelocytic leukemia and prognostic evaluation.HSP90 Inhibitor Geldanamycin as a Radiation Response Modificator in Human Blood Cells Phytonutrients Differentially Stimulate NAD(P)H:Quinone Oxidoreductase, Inhibit Proliferation, and Trigger Mitotic Catastrophe in Hepa1c1c7 Cells NRF2 and the Phase II Response in Acute Stress Resistance Induced by Dietary Restriction.KEAP1 is a redox sensitive target that arbitrates the opposing radiosensitive effects of parthenolide in normal and cancer cells Understanding the role of NRF2-regulated miRNAs in human malignancies.Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9 Free radical oxidation of cardiolipin: chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and human diseases.Molecular mechanisms of hypolipidemic effects of curcumin.The role of nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cells.Role of dietary pro-oxidants in the maintenance of health and resilience to oxidative stress.SILAC-based quantitative proteomic analysis reveals widespread molecular alterations in human skin keratinocytes upon chronic arsenic exposure.Okanin, a chalcone found in the genus Bidens, and 3-penten-2-one inhibit inducible nitric oxide synthase expression via heme oxygenase-1 induction in RAW264.7 macrophages activated with lipopolysaccharide.Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia.Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants.Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.Label-free and facile electrochemical biosensing using carbon nanotubes for malondialdehyde detection.Exploring the oxidative stress response mechanism triggered by environmental water samples.Cell-Based Assay for Identifying the Modulators of Antioxidant Response Element Signaling Pathway.Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy.Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia.Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara.

P2860

Q26864239-F8C65A01-6CDF-4019-9469-431099FC755F Q28392051-CD211277-B942-4411-B178-9BE8589F8202 Q28393090-090A8E43-908F-4D6A-AEB1-432C46D081DC Q28743757-0BCF90D5-7F76-46B3-8F65-94A3C73E3A9D Q30100968-C5455945-6185-423D-ACD7-2CFB44B258EB Q33641296-9B73E671-544F-4825-9375-D9D2FC631944 Q33668627-81D513C4-E616-4B77-A937-270AC8AA6B6F Q33784238-5F66DD1E-B851-445C-9D7F-2D8BF5D1D9F3 Q34231446-EC000A8A-4425-47F8-ACDA-31D555AAD3DE Q34455737-B52E0006-FA0E-4B43-BE25-91EB6A8380C7 Q35039225-89351636-5204-4CA1-9C2B-F885AECA4315 Q35048614-50AE4392-BDDB-41C9-B75D-7F703DB1D6AD Q35102971-FD99E253-B912-4E93-9E36-825AD1CB9CCC Q35667423-A0621A26-4B2E-41B9-9089-EA8D8F6AA60F Q35925853-F8A45DD9-806F-47D4-9D24-DE1790074618 Q36059668-C941D475-2D7C-4F35-8BFF-836D6D615684 Q36336147-7FD7C6F4-3D38-43D6-B0D3-1A939A9C9568 Q36358976-9889CD1C-4CFC-4A66-B78F-5A3110F9FEA6 Q36475974-0D1F3393-2AA3-4516-87F1-D24F12315065 Q36678635-1B727EA1-C6EB-4194-9D09-41DDC10C1A49 Q37025047-DB3C48E3-ADFC-4F45-9AD3-D3690E60FA56 Q37207646-B18343C9-D666-4069-88AD-2FDEB75B6F99 Q37696319-C791D334-98D4-43BF-A252-9B66CC28841C Q37999099-38721CAC-3668-4EAC-BB91-3FDF3B9FFB00 Q38075862-13031E19-A74C-4665-A3E2-7CEDEDCB8C75 Q38161353-E28A4808-49D1-481B-85DC-6B20A739B750 Q38302563-BA0730BC-6F34-4CE7-8C29-9448EDC69957 Q38725013-91FC3B2F-3916-4BB5-AFAE-E2B686EABD5C Q39995874-DCBC5FBC-16BB-4B87-B7A4-B9AD1D03CFE0 Q40147208-3EA42409-76C4-468A-9B8F-0478560BA392 Q40972934-BBC1B313-EF31-409D-82B2-F3C01A0D5975 Q41882913-5BBAB605-C44B-4D41-84A5-1AAAAB3C85DE Q43609217-BC1F7B49-5D61-4E63-B716-6388189A84FD Q46441132-12EC8A50-0AB9-4E68-A3BF-100D14C3A6AA Q46502520-74D03D73-6EFE-4570-B37C-6F89963EE0FD Q50874501-7C07EDC6-4094-4394-B6ED-BDC0BED6E939 Q51075776-7ED30015-F4D4-4BD4-BE5A-D62326B99069 Q55017371-B1B8BB9F-227A-4DA8-9670-C49363F61FB0 Q55709567-D83E924C-AE04-4FD6-A832-2098423D9BC9

P2860

Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q33841975

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Nrf2 responses and the therape ...... chronic lymphocytic leukemia.

@ast

Nrf2 responses and the therape ...... chronic lymphocytic leukemia.

@en

type

label

Nrf2 responses and the therape ...... chronic lymphocytic leukemia.

@ast

Nrf2 responses and the therape ...... chronic lymphocytic leukemia.

@en

prefLabel

Nrf2 responses and the therape ...... chronic lymphocytic leukemia.

@ast

Nrf2 responses and the therape ...... chronic lymphocytic leukemia.

@en

P1433

Q33841975-E735CC1A-9534-4FDB-8784-B1C5F3ACBAE5

P1476

Q33841975-2DF69731-E696-451F-B526-A364CB1F535F

P2093

Q33841975-05A4BD3E-03C1-4704-8AD7-7FFB15F8C348

Q33841975-0B9E0690-CA83-4905-B24B-164238E5566E

Q33841975-44D6DF08-F437-442B-86E7-69533687BDB4

Q33841975-5AD47A07-E21E-48B3-A30F-1A1820F120C6

Q33841975-71D50AA4-1328-47A0-BD9D-1EF7763EA2C4

Q33841975-8F694E12-5A9F-41DE-9B63-FFBC97B4E815

Q33841975-948407B9-BDFA-40D6-A979-EBED87191029

Q33841975-C2F5E243-1097-4E4B-9A46-3E8DDE15DF29

Q33841975-D092DB2E-DA66-459F-8FAD-62F78C274DEC

Q33841975-D6C21D24-5E37-4C9F-B4AE-801370D82B31

P2860

Q33841975-07157E70-95E9-46C4-BF12-B44C9008D2F1

Q33841975-0BCF3826-E470-464D-865D-C2CD511489DB

Q33841975-0F578C56-3534-491C-935A-75BD0FE3954A

Q33841975-1B02E2F5-3FB5-4BD6-9160-51E043FEE9B3

Q33841975-277E966B-3EAF-435B-927E-8219177B2247

Q33841975-2848EDF1-43F3-4758-8647-395E688BC953

Q33841975-28E1F813-5B63-4823-8253-B44DDF87BC10

Q33841975-2B9B61C1-F577-4791-A232-8B9B9E67AFE5

Q33841975-3129FED3-FFAE-4871-B181-260E5B2E188F

Q33841975-35690396-93EE-432D-AF7D-4C039E55096E

P304

Q33841975-C154708F-59EE-4028-B3C5-0DB33127ACF7

P31

Q33841975-8DFEB1C6-9035-4F81-B13A-7865ACBC313D

P356

Q33841975-DCB2DE50-1FE3-414F-8808-AC8575A2CD65

P407

Q33841975-6A3ADB5A-AAED-4435-B59C-4A94FF75501A

P433

Q33841975-4CFA3E52-C034-41AE-9E37-8CABE97F68FF

P478

Q33841975-9A110842-6CDA-40F4-ADFA-08C4B360970B

P577

Q33841975-93CB2EBD-4CA9-41D9-BBD9-56F1356FF44B

P5875

Q33841975-2DF28202-19BD-4864-B102-E1AB187903F0

P698

Q33841975-BF7D8F4E-3EF7-4431-A257-FC255B98B002

P921

Q33841975-5042DF70-C72A-4949-A06B-9CDC093FC074

Q33841975-A08004CC-69B4-4B60-B821-1FF2986CAC46

P932

Q33841975-549C1C1A-A4B5-4E44-88B0-1E09F9163C9D

P356

PNAS.1002890107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Nrf2 responses and the therape ...... chronic lymphocytic leukemia.

@en

P2093

Christina C N Wu

http://www.w3.org/2001/XMLSchema#string

Dennis A Carson

http://www.w3.org/2001/XMLSchema#string

Guangyi Jin

http://www.w3.org/2001/XMLSchema#string

Howard B Cottam

http://www.w3.org/2001/XMLSchema#string

Maripat Corr

http://www.w3.org/2001/XMLSchema#string

Michael D Rosenbach

http://www.w3.org/2001/XMLSchema#string

Raymond P Wu

http://www.w3.org/2001/XMLSchema#string

Richard B Schwab

http://www.w3.org/2001/XMLSchema#string

Shiyin Yao

http://www.w3.org/2001/XMLSchema#string

Tomoko Hayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Free radicals and antioxidants in normal physiological functions and human disease

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress

A new mathematical model for relative quantification in real-time RT-PCR

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

Nrf2-Keap1 defines a physiologically important stress response mechanism

An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen

Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene

Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway

P304

7479-7484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1002890107

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43023402

http://www.w3.org/2001/XMLSchema#string

P698

20368435

http://www.w3.org/2001/XMLSchema#string

P921

P932

2867719

http://www.w3.org/2001/XMLSchema#string